X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (42) 42
oncology (40) 40
index medicus (37) 37
radiotherapy (36) 36
female (33) 33
middle aged (30) 30
male (28) 28
aged (25) 25
adult (18) 18
retrospective studies (17) 17
chemotherapy (15) 15
radiation-therapy (15) 15
radiology, nuclear medicine & medical imaging (15) 15
follow-up studies (14) 14
aged, 80 and over (13) 13
cancer (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
neoplasm staging (12) 12
therapy (12) 12
treatment outcome (12) 12
radiation therapy (10) 10
breast cancer (9) 9
hematology, oncology and palliative medicine (9) 9
radiation (9) 9
analysis (8) 8
medicine & public health (8) 8
breast neoplasms - radiotherapy (7) 7
disease-free survival (7) 7
irradiation (7) 7
prognosis (7) 7
prostate cancer (7) 7
radiology (7) 7
radiotherapy, adjuvant (7) 7
surgery (7) 7
breast neoplasms - mortality (6) 6
carcinoma (6) 6
intensity-modulated radiotherapy (6) 6
management (6) 6
multivariate analysis (6) 6
age factors (5) 5
breast neoplasms - pathology (5) 5
chemotherapy, adjuvant (5) 5
hematology (5) 5
radiology and nuclear medicine (5) 5
radiosurgery (5) 5
radiotherapy dosage (5) 5
survival (5) 5
survival analysis (5) 5
survival rate (5) 5
system (5) 5
algorithms (4) 4
brachytherapy (4) 4
breast neoplasms - drug therapy (4) 4
cancer patients (4) 4
care and treatment (4) 4
chemoradiotherapy (4) 4
combined modality therapy (4) 4
diseases (4) 4
dose fractionation (4) 4
feasibility studies (4) 4
fluorodeoxyglucose f18 (4) 4
head and neck cancer (4) 4
imrt (4) 4
mastectomy, segmental (4) 4
metastases (4) 4
metastasis (4) 4
organs at risk (4) 4
outcomes (4) 4
patients (4) 4
pregnancy (4) 4
proportional hazards models (4) 4
radiopharmaceuticals (4) 4
radiotherapy planning, computer-assisted (4) 4
recurrence (4) 4
safety (4) 4
stereotactic body radiotherapy (4) 4
toxicity (4) 4
tumors (4) 4
adjuvant treatment (3) 3
animals (3) 3
body (3) 3
body radiation-therapy (3) 3
breast neoplasms - surgery (3) 3
cardiac metastases (3) 3
cetuximab (3) 3
clinical trials (3) 3
cone-beam computed tomography (3) 3
conservative surgery (3) 3
conserving surgery (3) 3
diagnostic radiology (3) 3
dose-constraints (3) 3
experience (3) 3
further section · weitere sektionen (3) 3
glands (3) 3
hodgkin disease - drug therapy (3) 3
hodgkin disease - radiotherapy (3) 3
imaging / radiology (3) 3
induction chemotherapy (3) 3
interventional radiology (3) 3
italy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 919 - 923
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 3, pp. 725 - 726
Journal Article
The Breast Journal, ISSN 1075-122X, 11/2018, Volume 24, Issue 6, pp. 1019 - 1023
BRCA1/2 mutations are involved in breast cancer (BC) susceptibility but their influence on outcome is unclear. We reviewed BC patients tested for BRCA to... 
breast cancer | oncogenetics | BRCA1/2 mutation | hereditary cancer syndromes | SURVIVAL | ONCOLOGY | OUTCOMES | CARRIERS | OBSTETRICS & GYNECOLOGY | Care and treatment | Cancer patients | Breast cancer | Genetic aspects | Disease susceptibility | Chemotherapy | Mutation | BRCA1 protein | Patients | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 2, pp. 509 - 515
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 5, pp. 1077 - 1083
Purpose This multicenter retrospective study was designed to evaluate the prognostic role of interim fluorodeoxyglucose-labeled positron emission tomography... 
Radiology | Hematology, Oncology and Palliative Medicine | FDG-PET | CRITERIA | F-18-FDG PET | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | FREE SURVIVAL | SCAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Male | Radiotherapy, Image-Guided | Vinblastine - administration & dosage | Hodgkin Disease - radiotherapy | Positron-Emission Tomography - mortality | Time Factors | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Female | Remission Induction - methods | Retrospective Studies | Radiopharmaceuticals | Doxorubicin - administration & dosage | Radiotherapy Dosage | Dacarbazine - administration & dosage | Bleomycin - administration & dosage | Positron-Emission Tomography - methods | Disease-Free Survival | Regression Analysis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fluorodeoxyglucose F18 | Combined Modality Therapy - methods | Sects | Chemotherapy | Anthracyclines | PET imaging | Lymphomas | Radiotherapy | Cancer | Analysis | Radiation | LYMPHOMAS | DIAGNOSIS | MULTIVARIATE ANALYSIS | PATIENTS | POSITRON COMPUTED TOMOGRAPHY | DOXORUBICIN | FLUORODEOXYGLUCOSE | RADIOLOGY AND NUCLEAR MEDICINE | BLEOMYCIN | VINBLASTINE | RADIOTHERAPY | CHEMOTHERAPY
Journal Article
The Breast, ISSN 0960-9776, 12/2018, Volume 42, pp. 1 - 2
Ribociclib is a CDK4-6 inhibitor recently approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) as first-line treatment... 
Ribociclib | Concomitant radiotherapy | Breast cancer | Safety | ONCOLOGY | OBSTETRICS & GYNECOLOGY | Antimitotic agents | Analysis | Radiation | Metastasis | Radiotherapy | Antineoplastic agents | Drug approval
Journal Article
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 12/2017, Volume 120, pp. 98 - 110
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 02/2015, Volume 114, Issue 2, pp. 230 - 238
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 1, pp. 316 - 316
Journal Article